Investors

Press Releases

ObsEva Files half Year 2023 Financial Statements

September 27, 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – September 27, 2023 –…

ObsEva Recovers Full Worldwide Rights on Nolasiban

July 13, 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – July 13, 2023 – ObsEva SA (SIX: OBSN), a…

ObsEva SA Announces that Shareholders Approved all Board Proposals at its 2023 Annual General Meeting held on June 29, 2023

June 30, 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – June 30, 2023 –…

Annual General Meeting 2023

June 8, 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – June 8, 2023 – ObsEva SA (SIX: OBSN), a…

ObsEva Appoints Fabien de Ladonchamps as Chief Executive Officer

May 2, 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – May 2, 2023 –…

ObsEva Annual Report 2022

April 28, 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – April 28, 2023 – ObsEva SA (SIX: OBSN), a…

ObsEva Announces Change of Central Securities Depositary

April 20, 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – April 20, 2023 –…

ObsEva Files Year End 2022 Financial Statements

March 31, 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 31, 2023 –…

ObsEva Announces Progress Towards its Plans to Consolidate Operations in Switzerland: Delisting of OBSV from The Nasdaq Stock Market effective March 23, 2023

March 15, 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 15, 2023 –…

ObsEva Announces Update Towards its Strategic Reorganization to Consolidate Operations in Switzerland

March 13, 2023

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 13, 2023 –…

Stock Information

Latest Press Release

ObsEva Files half Year 2023 Financial Statements

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – September 27, 2023 –…

Investor Contact

IR@obseva.ch

Media Contact

Media

contact@obseva.ch

Sign up for news

* Type:

InvestorHCPNursePayerHospital PharmacistRetail PharmacistOther

* I have read and agreed to the privacy policy and I consent to the use of above personal data for the purpose of processing and answering my contact request.Read our privacy policy here.

* I agree to be updated with the latest ObsEva news via Newsletters.

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
cookielawinfo-checkbox-necessary	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
cookielawinfo-checkbox-others	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
cookielawinfo-checkbox-performance	1 year	Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".

Cookie	Duration	Description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_gat_UA-142597171-1	1 minute	A variation of the _gat cookie set by Google Analytics and Google Tag Manager to allow website owners to track visitor behaviour and measure site performance. The pattern element in the name contains the unique identity number of the account or website it relates to.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.

Cookie	Duration	Description
ak_bmsc	2 hours	No description available.
bm_mi	session	No description available.
cIAryJWe_gnK	1 day	No description
cookielawinfo-checkbox-functional	1 year	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
DrupalVisitorMobile	session	No description available.
FBPaERDUCrISwlj	1 day	No description
iJgdRNehCrMt	1 day	No description
uAoLMBTksZiH-hn	1 day	No description

Press Releases

ObsEva Files half Year 2023 Financial Statements

ObsEva Recovers Full Worldwide Rights on Nolasiban

ObsEva SA Announces that Shareholders Approved all Board Proposals at its 2023 Annual General Meeting held on June 29, 2023

Annual General Meeting 2023

ObsEva Appoints Fabien de Ladonchamps as Chief Executive Officer

ObsEva Annual Report 2022

ObsEva Announces Change of Central Securities Depositary

ObsEva Files Year End 2022 Financial Statements

ObsEva Announces Progress Towards its Plans to Consolidate Operations in Switzerland: Delisting of OBSV from The Nasdaq Stock Market effective March 23, 2023

ObsEva Announces Update Towards its Strategic Reorganization to Consolidate Operations in Switzerland

Stock Information

Latest Press Release

Investor Contact

Media Contact

Sign up for news

Are you sure you want to leave ObsEva.com?

Disclaimer

Disclaimer